Business
2 views
Indian pharma firms have little reason to fear Trump's tariff threat
Trump's pledge to apply 100% levy on firms making off-patent medications by 2028 (rising to 200% a year later) unless they move production to US faces formidable commercial and political obstacles

Business-standard Verified Source
Syndicated via official news feed
Explore all Business stories
Syndicated feed content with full publisher credit.
Business Desk
More in Business
Continue reading verified coverage and related developments on this desk.